日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With Gout

以目标为导向的降尿酸治疗与痛风患者的心血管结局

期刊:Jama Internal Medicine
影响因子:23.3
doi:10.1001/jamainternmed.2025.7453
Cipolletta, Edoardo; Zverkova Sandström, Tatiana; Rozza, Davide; Leyrat, Clemence; Nakafero, Georgina; Drivelegka, Panagiota; Avery, Anthony J; Mamas, Mamas A; Tata, Laila J; Dehlin, Mats; Abhishek, Abhishek
痛风
代谢
发表日期：2026
文献求助 收藏

Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in Sweden

别嘌醇的使用与痛风患者发生急性冠脉综合征的风险：一项基于瑞典人群的队列研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-092522
Drivelegka, Panagiota; Jacobsson, Lennart; Sandström, Tatiana Zverkova; Lindström, Ulf; Bengtsson, Karin; Dehlin, Mats
痛风
代谢
发表日期：2025
文献求助 收藏

Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017)

痛风、高尿酸血症与帕金森病风险之间的关联：瑞典西部的一项队列研究（2001-2017 年）

期刊:Rheumatology Advances in Practice
影响因子:2.1
doi:10.1093/rap/rkaf102
Dehlin, Mats; Bergquist, Filip; Drivelegka, Panagiota; Sandström, Tatiana Zverkowa; Jacobsson, Lennart T H
痛风
帕金森
神经科学
代谢
发表日期：2025
文献求助 收藏

Association between serum level of urate and subclinical atherosclerosis: results from the SCAPIS Pilot

血清尿酸水平与亚临床动脉粥样硬化的关联：SCAPIS试点研究结果

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-020-2119-0
Drivelegka, Panagiota; Forsblad-d'Elia, Helena; Angerås, Oskar; Bergström, Göran; Schmidt, Caroline; Jacobsson, Lennart T H; Dehlin, Mats
SCAP
心血管
动脉粥样硬化
发表日期：2020
文献求助 收藏

Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

首次诊断痛风时的合并症：性别差异可能对降尿酸治疗的剂量产生影响

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-018-1596-x
Drivelegka, Panagiota; Sigurdardottir, Valgerdur; Svärd, Anna; Jacobsson, Lennart T H; Dehlin, Mats
痛风
代谢
发表日期：2018
文献求助 收藏

Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

更正：首次诊断时痛风合并症：性别差异可能对降尿酸治疗剂量产生影响

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-018-1700-2
Drivelegka, Panagiota; Sigurdardottir, Valgerdur; Svärd, Anna; Jacobsson, Lennart T H; Dehlin, Mats
痛风
代谢
发表日期：2018
文献求助 收藏

Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study

痛风患者和普通人群肾结石发生率及危险因素的队列研究

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-017-1376-z
Landgren, A J; Jacobsson, L T H; Lindström, U; Sandström, T Z S; Drivelegka, P; Björkman, L; Fjellstedt, E; Dehlin, M
痛风
肾结石
毒理研究
代谢
发表日期：2017
文献求助 收藏

Incidence and prevalence of gout in Western Sweden

瑞典西部痛风的发病率和患病率

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-016-1062-6
Dehlin, Mats; Drivelegka, Panagiota; Sigurdardottir, Valgerdur; Svärd, Anna; Jacobsson, Lennart T H
痛风
代谢
发表日期：2016
文献求助 收藏